1. India Stocks

  2. •

    Basic Materials

  3. •

    Agricultural Inputs
Hindustan Motors Limited

Hindustan Motors Limited

HINDUST.BO
Hindustan Motors LimitedIN flagBombay Stock Exchange
42.99
INR
+0.99
- -
189.16MMarket Cap
Hindustan Motors Limited
HINDUST.BO
(Bombay Stock Exchange)

Recent

price

42.99

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
- -
0.14
0.12
0.14
0.43
0.14
0.14
0.17
0.16
0.17
- -
0.1
Revenue per Share
- -
0.25
-1.35
-0.26
0.74
-0.33
-0.22
22.4
1.07
-0.69
- -
0.31
Basic EPS, GAAP
- -
-0.5
-0.25
-0.61
-1.47
2.42
11.75
-14.82
0.02
0.15
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
5.92
4.58
3.98
4.73
10
10
10
27.65
26.83
- -
10.01
Book Value per Share
- -
6.3
4.62
4.36
5.1
4.77
4.55
26.95
28.01
27.2
- -
27.65
Tangible Book Value per Share
- -
4
4
4
4
4
4
4
4
4
- -
4
Basic Weighted Avg Shares
- -
1
1
1
2
1
1
1
1
1
- -
- -
Sales/Revenue/Turnover
- -
-168.5
-216.51
-269.53
-45.56
-217.63
-280.14
-885.08
-472.92
-847.86
-867.44
-867.21
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
1
-6
-1
3
-1
-1
99
5
-3
1
1
Net Income, GAAP
- -
36.83
2,497.85
- -
- -
- -
- -
0.5
22.53
- -
50.22
50.22
Effective Tax Rate (%)
- -
173.5
-1,162.49
-190.24
174.45
-239.84
-155.43
13,574.76
651.94
-395.59
309.93
309.93
Profit Margin (%)
14
16
16
13
10
8
7
108
116
113
113
113
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
27
28
20
19
22
21
20
119
123
120
122
122
Total Equity
- -
-2.48
110.3
- -
- -
- -
- -
-9.23
-2.18
- -
-1.55
-1.55
Return on Invested Capital (%)
- -
4.31
-25.68
- -
- -
- -
- -
224.04
5.81
- -
1.71
1.71
Return on Capital (%)
- -
4.31
-25.68
-6.18
17.05
-4.49
-2.21
224.04
5.67
-2.54
1.65
1.65
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
- -
4
Market Capitalization
271
230
191

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
120
- -
114
Cash, Cash Equivalents & STI
93
- -
89
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
47.3%
98.12%
1.12%
Free Cash Flow
- -
303.72%
703.44%
Net Income, GAAP
- -
-2,138.87%
-144%
Sales/Revenue/Turnover
- -
-3.68%
-43.84%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1
2025
- -
- -
- -
- -
1
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.33
0.16
0.51
- -
1.07
2025
0.1
0.4
0.06
-1.17
-0.69
2026
0.91
0.43
-0.1
-0.94
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Itafos Inc. (MBCF)
Anhui Huilong Agricultural Means of Production Co.,Ltd. (002556.SZ)
ADAMA Ltd. (200553.SZ)
Kunming Chuan Jin Nuo Chemical Co., Ltd. (300505.SZ)
Bharat Rasayan Limited (BHARATRAS.BO)
Fertoz Limited (FTZ.AX)
Business
Hindustan Agrigenetics Ltd engages in the processing and trading of seeds in India. Incorporated in 1990 and headquartered in New Delhi, the company develops, produces, and markets hybrid seeds including sunflower, cotton, jowar, bajra, fodder jowar, and tomato varieties; tissue culture plantlets such as ornamental plants like syngonium, orchids, chrysanthemum, spathiphyllum, and horticulture plants including strawberry, grapes, and bananas; and floriculture products. It operates primarily in the agricultural biotechnology sector, targeting farmers with a focus on seeds, tissue culture technologies, and emerging digital solutions for agricultural information needs, with historical exports of tissue culture products to countries including Holland, Spain, Belgium, and the USA. In a significant recent development, Rajendra Naniwadekar completed the acquisition of an additional 26% stake in September 2025, increasing his holding to over 50% from 24%, funded by internal resources through a tender offer managed by Bajaj Capital Holdings Ltd; the company also approved unaudited financial results for quarters ended June 30, 2025, and September 30, 2024, alongside board meetings for strategic approvals including potential registered office shifts and director appointments at its 34th annual general meeting in September 2024.